Thal LJ - Search Results

1

Emergent psychopathology in Alzheimer's disease patients over 12 months associated with functional, not cognitive, changes.

Tractenberg RE, Weiner MF, Patterson MB, Gamst A, Thal LJ. Tractenberg RE, et al. Among authors: thal lj. J Geriatr Psychiatry Neurol. 2002 Summer;15(2):110-7. doi: 10.1177/089198870201500210. J Geriatr Psychiatry Neurol. 2002. PMID: 12083593

2

Assessing Alzheimer's disease patients with the Cohen-Mansfield Agitation Inventory: scoring and clinical implications.

Weiner MF, Tractenberg RE, Jin S, Gamst A, Thomas RG, Koss E, Thal LJ. Weiner MF, et al. Among authors: thal lj. J Psychiatr Res. 2002 Jan-Feb;36(1):19-25. doi: 10.1016/s0022-3956(01)00047-4. J Psychiatr Res. 2002. PMID: 11755457

3

Estimating the prevalence of agitation in community-dwelling persons with Alzheimer's disease.

Tractenberg RE, Weiner MF, Thal LJ. Tractenberg RE, et al. Among authors: thal lj. J Neuropsychiatry Clin Neurosci. 2002 Winter;14(1):11-8. doi: 10.1176/jnp.14.1.11. J Neuropsychiatry Clin Neurosci. 2002. PMID: 11884649 Clinical Trial.

4

No long-term effect of behavioral treatment on psychotropic drug use for agitation in Alzheimer's disease patients.

Weiner MF, Tractenberg RE, Sano M, Logsdon R, Teri L, Galasko D, Gamst A, Thomas R, Thal LJ. Weiner MF, et al. Among authors: thal lj. J Geriatr Psychiatry Neurol. 2002 Summer;15(2):95-8. doi: 10.1177/089198870201500208. J Geriatr Psychiatry Neurol. 2002. PMID: 12083600 Clinical Trial.

5

Investigating emergent symptomatology as an outcome measure in a behavioral study of Alzheimer's disease.

Tractenberg RE, Gamst A, Thomas RG, Patterson M, Schneider LS, Thal LJ. Tractenberg RE, et al. Among authors: thal lj. J Neuropsychiatry Clin Neurosci. 2002 Summer;14(3):303-10. doi: 10.1176/jnp.14.3.303. J Neuropsychiatry Clin Neurosci. 2002. PMID: 12154155 Free PMC article.

6

Nerve growth factor gene therapy for Alzheimer's disease.

Tuszynski MH, Thal L, U HS, Pay MM, Blesch A, Conner J, Vahlsing HL. Tuszynski MH, et al. J Mol Neurosci. 2002 Aug-Oct;19(1-2):207. doi: 10.1007/s12031-002-0034-2. J Mol Neurosci. 2002. PMID: 12212782 Clinical Trial. No abstract available.

7

Brain MRI hippocampal volume and prediction of clinical status in a mild cognitive impairment trial.

Grundman M, Sencakova D, Jack CR Jr, Petersen RC, Kim HT, Schultz A, Weiner MF, DeCarli C, DeKosky ST, van Dyck C, Thomas RG, Thal LJ; Alzheimer's Disease Cooperative Study. Grundman M, et al. Among authors: thal lj. J Mol Neurosci. 2002 Aug-Oct;19(1-2):23-7. doi: 10.1007/s12031-002-0006-6. J Mol Neurosci. 2002. PMID: 12212787

8

Age at onset is associated with disease severity in Lewy body variant and Alzheimer's disease.

Ho GJ, Hansen LA, Alford MF, Foster K, Salmon DP, Galasko D, Thal LJ, Masliah E. Ho GJ, et al. Among authors: thal lj. Neuroreport. 2002 Oct 7;13(14):1825-8. doi: 10.1097/00001756-200210070-00028. Neuroreport. 2002. PMID: 12395133

9

Decline in verbal memory during preclinical Alzheimer's disease: examination of the effect of APOE genotype.

Lange KL, Bondi MW, Salmon DP, Galasko D, Delis DC, Thomas RG, Thal LJ. Lange KL, et al. Among authors: thal lj. J Int Neuropsychol Soc. 2002 Nov;8(7):943-55. doi: 10.1017/s1355617702870096. J Int Neuropsychol Soc. 2002. PMID: 12405546 Free PMC article.

10

Estrogen levels do not correlate with improvement in cognition.

Thal LJ, Thomas RG, Mulnard R, Sano M, Grundman M, Schneider L. Thal LJ, et al. Arch Neurol. 2003 Feb;60(2):209-12. doi: 10.1001/archneur.60.2.209. Arch Neurol. 2003. PMID: 12580705 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

300 results

Search Page

Filters